Results 91 to 100 of about 16,509 (247)

Fibrin and Fibrinogen Degradation Products in Chronic Subdural Hematoma

open access: yesNeurologia medico-chirurgica, 1975
Fibrin and fibrinogen degradation products (FDP) were examined in 30 cases of chronic subdural hematoma. Fibrinogen was not found in the contents of subdural hematoma in 29 cases, and only a small amount of fibrinogen was detected in the remaining case. The liquefied hematoma content was not coagulated by the addition of thrombin.
ITO, Haruhide   +2 more
openaire   +3 more sources

An in vitro comparison of PDGF‐BB release from composite graft materials containing leukocyte‐rich platelet‐rich fibrin and platelet‐derived growth factor‐BB and β‐tricalcium phosphate

open access: yesJournal of Periodontology, EarlyView.
Abstract Background The clinical efficacy of growth factors in regenerative procedures may depend on both dosage and sustained delivery during critical phases of healing. This study aimed to evaluate in vitro release kinetics of platelet‐derived growth factor‐BB (PDGF‐BB) from various graft materials, including recombinant human PDGF‐BB (rhPDGF‐BB ...
Farahnaz Fahimipour   +4 more
wiley   +1 more source

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events

open access: yesPhytotherapy Research, EarlyView.
An overview of the role of natural products (NP) in cardiovascular disease prevention, highlighting key mechanisms of action: including antiplatelet, antithrombotic, anti‐inflammatory, and antioxidant effects. Additionally, it illustrates the integration of diet–drug interactions, nutritional epigenetics, and the role of artificial intelligence in ...
Maria Nektaria Magkoulia   +1 more
wiley   +1 more source

Fibrin and fibrinogen degradation products in plasma : clinical and methodological studies using enzyme immuno assays [PDF]

open access: yes, 1992
This thesis comprises studies with monoclonal antibody-based plasma assays for derivatives of fibrin and fibrinogen in patients with diseases and conditions characterized by an activated state of coagulation and ...
Kroneman, H. (Herman)
core   +1 more source

Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions?

open access: yesClinics, 2009
OBJECTIVE: The aim of this study was to identify the participation of the coagulation system in the differential diagnosis of pleural effusions. INTRODUCTION: Imbalance between immunologic and metabolic factors triggers a sequence of events resulting in ...
Marcelo Alexandre Costa Vaz   +5 more
doaj   +1 more source

Nonthermal plasma approaches for combating implant‐associated infections: A compendious review

open access: yesVIEW, EarlyView.
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe   +8 more
wiley   +1 more source

[Degradation products of fibrinogen in synovial fluid].

open access: yes, 1979
The fibrin/fibrinogen degradation products were measured in 24 synovial fluids sampled from patients with knee joint effusion. It has been observed that they are increased in synovial fluid involved in inflammatory processes.
PENGO, VITTORIO   +4 more
core  

Optimal Hypoxia Mimetic Small Molecules for Enhancing Angiogenic Properties of Stem Cells From Human Exfoliated Deciduous Teeth

open access: yesInternational Endodontic Journal, EarlyView.
ABSTRACT Aim Hypoxic preconditioning of cells holds promise for regenerative therapies, yet identifying effective and safe methods for clinical application remains challenging. We aimed to determine optimal hypoxia‐mimetic small molecules (SMs) that stabilize hypoxia‐inducible factor‐1α (HIF‐1α) and their dosages for hypoxic preconditioning in stem ...
Hong Wang   +9 more
wiley   +1 more source

Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage

open access: yes, 1985
In 48 patients with a subarachnoid hemorrhage, levels of fibrin/fibrinogen degradation products (FDP's), total protein, and plasminogen were measured in the cerebrospinal fluid (CSF) between Days 9 and 15 after the bleed.
van Vliet, H. H.   +4 more
core   +1 more source

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

open access: yesNeuropsychiatric Disease and Treatment, 2015
Masamichi Ishioka, Norio Yasui-Furukori, Norio Sugawara, Hanako Furukori, Shuhei Kudo, Kazuhiko Nakamura Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan Objective: The strong association between ...
Ishioka M   +5 more
doaj  

Home - About - Disclaimer - Privacy